ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX
· Real-Time Price · USD
1.69
-0.01 (-0.59%)
At close: Jun 17, 2025, 2:16 PM
-0.59% (1D)
| Bid | 1.65 |
| Market Cap | 74.79M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -22.12M |
| EPS (ttm) | -0.64 |
| PE Ratio (ttm) | -2.63 |
| Forward PE | -3.41 |
| Analyst | Hold |
| Ask | 1.69 |
| Volume | 30,669 |
| Avg. Volume (20D) | 153,246 |
| Open | 1.68 |
| Previous Close | 1.70 |
| Day's Range | 1.67 - 1.70 |
| 52-Week Range | 1.40 - 7.88 |
| Beta | 1.58 |
About EPIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EPIX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EPIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+8.59%
ESSA Pharma shares are trading higher after disclo...
Unlock content with
Pro Subscription
7 months ago
-73.08%
ESSA Pharma shares are trading lower after the company announced it terminated its Phase 2 study evaluating masofaniten combined with enzalutamide in patients with mCRPC
